Speciality: Biochemistry Biomedical Scientist
Location: Beds and Herts
Duration: Temporary
Speciality: Haematology and BT Biomedical Scientist
Location: East Of England
Duration: Temporary
Speciality: Histology
Location: South East Coast
Duration: Temporary
Speciality: Haematology and BT Biomedical Scientist
Location: London
Duration: Temporary
Researchers have developed a new type of blood test that could be used to diagnose peanut allergies in a safer and more accurate way than current methods allow.
A team from the King's College London School of Immunology and Microbial Sciences and the Medical Research Council (MRC) have created a method called the mast activation test (MAT), which has the potential to be used to evaluate a variety of food allergy types.
At present, allergy diagnosis relies on tools such as skin-prick tests, which can result in over-diagnosis. Indeed, only 22 per cent of school-aged children in the UK who test positively for peanut allergies via this method actually prove to be allergic when fed the food in a monitored setting.
Feeding tests are also sometimes used in a diagnostic setting, but this can be time-consuming and runs the risk of leading to a severe allergic reaction or anaphylactic shock.
By contrast, the MAT method works by focusing on mast cells, which are activated in the presence of immunoglobulin E, the antibody that causes allergic reactions through its interaction with peanut proteins. By detecting biomarkers associated with this reaction, the MAT can deliver an accurate diagnosis with no risk of false-positives or allergic responses, while also being five times more cost-effective than the feeding test.
Study leader Dr Alexandra Santos, an MRC clinician scientist from King's College London's Peter Gorer Department of Immunobiology, said: "We are adapting this test to other foods, such as milk, eggs, sesame and tree nuts. This test will be useful as we are seeing more and more children who have never been exposed to these foods because they have severe eczema or have siblings with allergies."
Written by Martin Lambert
Mediplacements is a genuine specialist medical recruitment company. Contact us to see the latest biomedical science jobs.
As tumours grow, new cancer cells replace old ones, which die off and release their DNA into the bloodstream....
Chronic transplant rejection can be deadly, and recognising it as early as possible is key to achieving the best...
The Ebola virus has the potential to spread very quickly from patient to patient, and therefore has caused...
A new tumour analysis test has been used to provide more information about cancer in children; something that...